PKC ε inhibitor peptide is an octapeptide that selectively and reversibly inhibits the translocation of Protein Kinase C epsilon. Inhibition of PKCε translocation is relevant to the study of norepinephrine-mediated regulation of contraction in cardiomyocytes.
1. Johnson, J A., et al., 1996. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. The Journal of biological chemistry. 271(40): 24962-6. PMID: 8798776
2. Yedovitzky, M., et al., 1997. Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. The Journal of biological chemistry. 272(3): 1417-20. PMID: 8999804
See how others have used PKC ε inhibitor peptide. Click on the entry to view the PubMed entry .
PMID: # 32781622 Jang, S.|Lee, S.|Park, H.| et al. 2020. Molecules. 25:
PMID: # 27330081 Sen, A. et al. 2016. The Journal of biological chemistry. 291: 16462-76.
PMID: # 25672459 Li, L. et al. 2015. Molecular medicine reports. 11: 4373-80.
PMID: # 24338688 2014. The Journal of biological chemistry. 289: 3148-63.
PMID: # 24806747 2014. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme. 46: 390-6.
PMID: # 25490397 2014. PloS one. 9: e113485.
PMID: # 20615477 2010. Prostaglandins & other lipid mediators. 93: 84-92.
PMID: # 20299424 2010. The Journal of pharmacology and experimental therapeutics. 333: 970-5.
PMID: # 19706599 Gayen, JR. et al. 2009. The Journal of biological chemistry. 284: 28498-509.
PMID: # 18039843 2008. Molecular and cellular biology. 28: 1007-17.